John Rearick, PhD, has experience in a range of chemical technologies at various stages of development, enabling him to craft strategic IP protection that helps position clients’ technology for licensing and partnering opportunities. Specializing in organic synthesis and medicinal chemistry, Dr. Rearick is adept at placing emphasis on technical details while always keeping in mind each client’s big-picture goals. Mr. Rearick is a Massachusetts Super Lawyers Rising Star.
Intellectual Property Protection: drafts and prosecutes patent applications on behalf of public and private institutions, biotechnology companies and pharmaceutical companies, with specific expertise in pharmaceuticals.
Dr. Rearick was the recipient of a Howard Hughes Medical Institute Predoctoral Fellowship in Biological Sciences and a Certificate of Distinction in Teaching from Harvard College. As a graduate student he also served as co-chair of the Graduate Student and Postdoc Council in the Department of Chemistry and Chemical Biology. At Purdue University, Dr. Rearick was a Lilly-Purdue Alumni Scholar, an active participant and leader in vocal music groups and served as team captain of the mock trial team. Dr. Rearick also spent two summers as a summer research intern at Eli Lilly & Co.
- Prepares and prosecutes patent applications relating to pharmaceutical products and related methods of preparation and use.
- Manages licensed university portfolios of developmental-stage pharmaceuticals.
- Assists in preparations of freedom-to-operate and validity opinions regarding various aspects of chemical and pharmaceutical products.
- Conducts due diligence review and analysis associated with in-licensing of pharmaceutical products.
- Represented large, multinational company’s strategic partnership with small pharmaceutical company.
Publications and Presentations
- “Translational Research in Biomaterials Seminar Series,” presenter, Boston University, Boston, May 2014.
- “The Legal Profession: Explore Careers,” panelist, Harvard University, Cambridge, November 2013.
- “Synthesis of Skeletally Diverse Small Molecules with Non-Natural Motifs: A Boronic Ester Annulation Strategy,” poster presentation, Broad Institute of Harvard and MIT Annual Meeting, Boston, November 2005.
- “Synthesis of Skeletally Diverse Small Molecules with Non-Natural Motifs: A Boronic Ester Annulation Strategy,” speaker, HHMI Meeting of Predoctoral Fellows, Chevy Chase, MD, September 2005.
- “Design and Synthesis of a Novel Series of 1,2-Disubstituted Cyclopentanes as Small, Potent Potentiators of 2-Amino-3-(3-hydrox-5-methyl-isoxazol-4-yl)propanoic Acid (AMPA) Receptors,” co-author, Journal of Medicinal Chemistry, 2002.
- “Asymmetric Synthesis of Umuravumbolide,” co-author, Organic Letters, 2001.
Professional and Community Involvement
Dr. Rearick is a member of the American Chemical Society and the Boston Patent Law Association. He has also served as a Citizen Teacher in the Citizen Schools legal apprenticeship, an after school enrichment program run in conjunction with non-profit Discovering Justice.
Education & Credentials
- Boston University School of Law
- JD, 2013
- Harvard University
- PhD, 2007
- Harvard University
- AM, 2004
- Purdue University
- BS, 2001
U.S. Patent & Trademark Office
Choate represented FORMA Therapeutics in its recent cross-border collaboration and license agreement with the University of Oxford.
Four Choate attorneys – Mark DeFeo, Renat Lumpau, John Rearick, and Anita Spieth – have been named counsel at the Firm, effective May 1, 2017.